MDV9300

Medivation Initiates Phase 2 Trial of MDV9300: Stock Rises 5.7%
Yahoo/Market Realist
Sat, 12/26/15 - 08:46 pm
Medivation
MDV9300
clinical trials
diffuse large B-cell lymphoma